Aspirin 'lowers melanoma risk' in women

11 March 2013

Women that take aspirin could be at a significantly lower risk of developing melanoma, according to a new study.

Published in the American Cancer Society Journal, the research suggests that aspirin's anti-inflammatory effects could help to protect against a skin cancer diagnosis and the benefits are greater the longer a female takes it.

This is based on observations of 59,806 caucasian US women aged between 50 and 79 for an average of 12 years.

Leader of the study Jean Tang, of Stanford University School of Medicine, claims that females who used aspirin had a 21 per cent lower risk of melanoma relative to non-users.

What's more, each incremental increase in duration of aspirin use yielded an 11 per cent lower risk of melanoma.

Using this logic, a woman that has used aspirin for five or more years has a 30 per cent lower melanoma risk than a female that does not use the drug.

Currently, it is unknown if the same effect occurs in males and further research is needed.

Posted by Philip Briggs

Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.

Find a treatment, test or scan available at:


Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.


Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...



© Spire Healthcare Group plc (2016)